Literature DB >> 30642849

Large cell neuroendocrine carcinoma of the uterine cervix.

Amir Habeeb1, Hany Habeeb2.   

Abstract

We report a case of large cell neuroendocrine carcinoma of the uterine cervix. A 33-year-old woman presented with a 4-month history of irregular vaginal bleeding and suspicious cervix. Transvaginal ultrasound showed a 3×3.8 cm cervical mass with a marked increase in the blood flow. MRI pelvis showed an exophytic tumour with left external iliac lymph node metastasis. Immunohistochemistry of the tumour cells showed strong positivity for the neuroendocrine markers synaptophysin and a very high Ki67 proliferation index. A diagnosis of high-grade large cell neuroendocrine carcinoma of the uterine cervix was made with FIGO stage IIA2. She was treated with chemotherapy and palliative radiotherapy but died 21 months after presenting. Neuroendocrine tumour of the uterine cervix is an extremely aggressive cancer with the late presentation-the need for a more rigorous treatment protocol as well as potential screening methods could improve outcomes for these patients. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  gynecological cancer; obstetrics and gynaecology

Mesh:

Substances:

Year:  2019        PMID: 30642849      PMCID: PMC6340556          DOI: 10.1136/bcr-2018-225880

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Large cell neuroendocrine [corrected] carcinoma of the uterine cervix: a clinicopathologic study of 12 cases.

Authors:  C B Gilks; R H Young; D J Gersell; P B Clement
Journal:  Am J Surg Pathol       Date:  1997-08       Impact factor: 6.394

2.  The carcinoid syndrome and multiple hormone secretion associated with a carcinoid tumour of the uterine cervix. Case report.

Authors:  A D Stockdale; M Leader; R H Phillips; K Henry
Journal:  Br J Obstet Gynaecol       Date:  1986-04

3.  Neuroendocrine cervical carcinoma: a diagnostic and therapeutic challenge.

Authors:  A Bermúdez; S Vighi; A García; J Sardi
Journal:  Gynecol Oncol       Date:  2001-07       Impact factor: 5.482

Review 4.  Neuroendrocrine tumors of the uterine cervix: A therapeutic challenge for gynecologic oncologists.

Authors:  Angiolo Gadducci; Silvestro Carinelli; Giovanni Aletti
Journal:  Gynecol Oncol       Date:  2017-01-03       Impact factor: 5.482

Review 5.  The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems.

Authors:  David S Klimstra; Irvin R Modlin; Domenico Coppola; Ricardo V Lloyd; Saul Suster
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

6.  Endocrine cell hyperplasia of the uterine cervix. A precursor of neuroendocrine carcinoma of the cervix?

Authors:  J K Chan; W M Tsui; S Y Tung; R C Ching
Journal:  Am J Clin Pathol       Date:  1989-12       Impact factor: 2.493

7.  Endocrine tumors of the uterine cervix: incidence, demographics, and survival with comparison to squamous cell carcinoma.

Authors:  Margaret E McCusker; Timothy R Coté; Limin X Clegg; Fattaneh J Tavassoli
Journal:  Gynecol Oncol       Date:  2003-03       Impact factor: 5.482

8.  Small-cell neuroendocrine carcinoma of the cervix. A human papillomavirus type 18-associated cancer.

Authors:  M H Stoler; S E Mills; D J Gersell; A N Walker
Journal:  Am J Surg Pathol       Date:  1991-01       Impact factor: 6.394

9.  Endocrine tumors of the cervix: morphologic assessment, expression of human papillomavirus, and evaluation for loss of heterozygosity on 1p,3p, 11q, and 17p.

Authors:  C Mannion; W S Park; Y G Man; Z Zhuang; J Albores-Saavedra; F A Tavassoli
Journal:  Cancer       Date:  1998-10-01       Impact factor: 6.860

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.